OBJECTIVE -Confirmatory factor analysis (CFA) was used to test the hypothesis that the components of the metabolic syndrome are manifestations of a single common factor. RESEARCH DESIGN AND METHODS-Three different datasets were used to test and validate the model. The Spanish and Mauritian studies included 207 men and 203 women and 1,411 men and 1,650 women, respectively. A third analytical dataset including 847 men was obtained from a previously published CFA of a U.S. population. The one-factor model included the metabolic syndrome core components (central obesity, insulin resistance, blood pressure, and lipid measurements). We also tested an expanded one-factor model that included uric acid and leptin levels. Finally, we used CFA to compare the goodness of fit of one-factor models with the fit of two previously published four-factor models.RESULTS -The simplest one-factor model showed the best goodness-of-fit indexes (comparative fit index 1, root mean-square error of approximation 0.00). Comparisons of one-factor with four-factor models in the three datasets favored the one-factor model structure. The selection of variables to represent the different metabolic syndrome components and model specification explained why previous exploratory and confirmatory factor analysis, respectively, failed to identify a single factor for the metabolic syndrome.CONCLUSIONS -These analyses support the current clinical definition of the metabolic syndrome, as well as the existence of a single factor that links all of the core components. Diabetes Care 29:113-122, 2006T he metabolic syndrome refers to the clustering, within individuals, of several cardiovascular risk factors (1,2). The metabolic syndrome is highly prevalent (3) and is a risk factor for cardiovascular diseases (CVD), chronic kidney disease, and type 2 diabetes (4 -6). Several definitions of the metabolic syndrome have been used, but all include insulin resistance or glucose intolerance, hypertension, dyslipidemia, and central obesity (7-9). Hyperuricemia and hyperleptinemia have also been proposed as components of the metabolic syndrome (1,10,11), and clinical, epidemiological, genetic, and physiologic studies have shown associations between these traits and both the metabolic syndrome components and CVD outcomes (10 -22).A central question in understanding the metabolic syndrome is why these traits cluster in individuals. For example, is there one or are there several factors, such as genetic or lifestyle characteristics, that influence the expression of metabolic syndrome traits in individuals? In an attempt to answer this question, many investigators have used exploratory factor analysis (EFA). This technique is used to analyze the interrelatedness of measured variables, so as to explain their observed correlations in terms of a smaller group of latent (i.e., unmeasured) variables, termed factors. For example, in the field of sociology, education level, income, and job status may all be related, and their relationship may best be explained by the presence of...
Objective Evidence suggests that adherence to the Mediterranean (MedDiet) or MIND diet is neuroprotective but the association between these dietary patterns and cognition has not been evaluated in a nationally representative population of older US adults. Design Population-based cross-sectional study. Participants/setting Community-dwelling older adults from the Health and Retirement Study (n = 5,907). Measurements Adherence to dietary patterns was determined from food frequency questionnaires using a priori criteria to generate diet scores for MedDiet (range = 0–55) and MIND diet (range 0–15). Cognitive performance was measured using a composite test score of global cognitive function (range 0–27). Linear regression was used to compare cognitive performance across tertiles of dietary pattern. Logistic regression was used to examine the association between dietary patterns and clinically significant cognitive impairment. Models were adjusted for age, gender, race, educational attainment and other health and lifestyle covariates. Results Mean age of participants was 68 ± 10.8 years. Compared to those with low MedDiet score, participants with mid and high score were less likely to have poor cognitive performance (OR 0.85; 95% CI 0.71, 1.02: P = 0.08, and OR 0.65; 95% CI: 0.52, 0.81: P < 0.001, respectively) in fully adjusted models. Results for the MIND diet were similar. Higher score in each dietary pattern was independently associated with significantly better cognitive function (P < 0.001) in a dose-response manner (PTREND < 0.001). Conclusion In a large nationally representative population of older adults, greater adherence to the MedDiet and MIND diet was independently associated with better cognitive function and lower risk of cognitive impairment. Clinical trials are required to elucidate the role of dietary patterns in cognitive aging.
OBJECTIVE -Confirmatory factor analysis (CFA) was used to test the hypothesis that the components of the metabolic syndrome are manifestations of a single common factor. RESEARCH DESIGN AND METHODS-Three different datasets were used to test and validate the model. The Spanish and Mauritian studies included 207 men and 203 women and 1,411 men and 1,650 women, respectively. A third analytical dataset including 847 men was obtained from a previously published CFA of a U.S. population. The one-factor model included the metabolic syndrome core components (central obesity, insulin resistance, blood pressure, and lipid measurements). We also tested an expanded one-factor model that included uric acid and leptin levels. Finally, we used CFA to compare the goodness of fit of one-factor models with the fit of two previously published four-factor models.RESULTS -The simplest one-factor model showed the best goodness-of-fit indexes (comparative fit index 1, root mean-square error of approximation 0.00). Comparisons of one-factor with four-factor models in the three datasets favored the one-factor model structure. The selection of variables to represent the different metabolic syndrome components and model specification explained why previous exploratory and confirmatory factor analysis, respectively, failed to identify a single factor for the metabolic syndrome.CONCLUSIONS -These analyses support the current clinical definition of the metabolic syndrome, as well as the existence of a single factor that links all of the core components. Diabetes Care 29:113-122, 2006T he metabolic syndrome refers to the clustering, within individuals, of several cardiovascular risk factors (1,2). The metabolic syndrome is highly prevalent (3) and is a risk factor for cardiovascular diseases (CVD), chronic kidney disease, and type 2 diabetes (4 -6). Several definitions of the metabolic syndrome have been used, but all include insulin resistance or glucose intolerance, hypertension, dyslipidemia, and central obesity (7-9). Hyperuricemia and hyperleptinemia have also been proposed as components of the metabolic syndrome (1,10,11), and clinical, epidemiological, genetic, and physiologic studies have shown associations between these traits and both the metabolic syndrome components and CVD outcomes (10 -22).A central question in understanding the metabolic syndrome is why these traits cluster in individuals. For example, is there one or are there several factors, such as genetic or lifestyle characteristics, that influence the expression of metabolic syndrome traits in individuals? In an attempt to answer this question, many investigators have used exploratory factor analysis (EFA). This technique is used to analyze the interrelatedness of measured variables, so as to explain their observed correlations in terms of a smaller group of latent (i.e., unmeasured) variables, termed factors. For example, in the field of sociology, education level, income, and job status may all be related, and their relationship may best be explained by the presence of...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.